Skip to content

The role of respiratory virus in adults with asthma exacerbations in Guangzhou, South China

The role of respiratory virus in adults with asthma exacerbations in Guangzhou, South China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-12002935
Enrollment
Unknown
Registered
2012-09-13
Start date
2012-02-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial arhma

Interventions

three:just observation one-month follow-up without intervention

Sponsors

The first affiliated hospital of Guangzhou Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who aged 18-70,with diagnosed asthma,has two or more situations as followoing: 1. Signs and symptoms of airflow obstruction (i.e., cough, wheeze, shortness of breath, chest tightness) within past 48h; 2. Increased asthma symptoms resulting in hospital admission or clinic visit; 3. Beta bronchodilator use >4 inhalations/day on two consecutive days; 4. Increased dose or addition of a new asthma controller therapy within past wk; 5. best PEF test falls to 80% of the mean baseline morning value on two consecutive readings ortwo consecutive morning readings; 6. nocturnal awakenings due to asthma on two consecutive nights; 7. total asthma symptom score for the combined symptoms of chest tightness, breathlessness, coughing, and wheezing increases by >3 ordinal values from the mean baseline value on two consecutive days; 8. inability to go to school or work due to asthma for two consecutive days.

Exclusion criteria

Exclusion criteria: Patients with Chronic Obstructive Pulmonary Disease, bronchiectasis, severe organs dysfunction drug abuse, and other disease with wheeze.

Design outcomes

Primary

MeasureTime frame
the rate of respiratory virus infection;

Countries

China

Contacts

Public ContactChen Rongchang
chenrc@vip.163.com+86 13902273260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026